Genome-wide association studies (GWAS) have identified several key genetic variants linked to AIS, such as POC5, TTLL11, and LBX1, which offer new insights into the cellular and molecular underpinnings of the disease. This evidence concerns the gene POC5 and androgen insensitivity syndrome.